Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    MTE19 - Biology and Treatment of Thymoma / Thymic Carcinoma

    • Type: Meet the Expert (ticketed session)
    • Track: Medical Oncology
    • Presentations: 1
    • Moderators:N. n/a
    • Coordinates: 10/30/2013, 07:00 - 08:00, Bayside 102, Level 1
  • +

    MTE20 - Pathology of Mesothelioma

    • Type: Meet the Expert (ticketed session)
    • Track: Mesothelioma
    • Presentations: 1
    • Moderators:N. n/a
    • Coordinates: 10/30/2013, 07:00 - 08:00, Bayside 103, Level 1
  • +

    MTE21 - Genomics in Lung Cancer (FULL)

    • Type: Meet the Expert (ticketed session)
    • Track: Pathology
    • Presentations: 1
    • Moderators:N. n/a
    • Coordinates: 10/30/2013, 07:00 - 08:00, Bayside 104, Level 1
    • +

      MTE21a.1 - Genomics in Lung Cancer

      07:00 - 08:00  |  Author(s): R. Thomas

      • Abstract
      • Presentation

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MTE22 - A Practical Approach to the Incidental Pulmonary Nodule

    • Type: Meet the Expert (ticketed session)
    • Track: Pulmonology + Endoscopy/Pulmonary
    • Presentations: 2
    • Moderators:N. n/a
    • Coordinates: 10/30/2013, 07:00 - 08:00, Bayside 105, Level 1
  • +

    MTE23 - Screening Tools for a High Risk Population - Can We Screen for Early Mesothelioma?

    • Type: Meet the Expert (ticketed session)
    • Track: Mesothelioma
    • Presentations: 1
    • Moderators:N. n/a
    • Coordinates: 10/30/2013, 07:00 - 08:00, Bayside 106, Level 1
  • +

    MTE24 - Treatment of Cachexia Over the Next Five Years

    • Type: Meet the Expert (ticketed session)
    • Track: Supportive Care
    • Presentations: 1
    • Moderators:N. n/a
    • Coordinates: 10/30/2013, 07:00 - 08:00, Bayside Gallery A, Level 1
  • +

    MTE25 - Less than Pneumonectomy after XRT (High Dose Radiotherapy)

    • Type: Meet the Expert (ticketed session)
    • Track: Surgery
    • Presentations: 1
    • Moderators:N. n/a
    • Coordinates: 10/30/2013, 07:00 - 08:00, Bayside Gallery B, Level 1
  • +

    PL04 - How Can We Stop the Epidemic of Lung Cancer?

    • Type: Plenary Session
    • Track: Prevention & Epidemiology
    • Presentations: 5
    • Moderators:C. Amos
    • Coordinates: 10/30/2013, 08:15 - 09:45, Plenary Hall, Ground Level
    • +

      PL04.0 - N/A - Chair Intro

      08:15 - 08:20

      • Abstract

      No abstract available for this presentation

    • +

      PL04.1 - Risk Reduction by Stopping Smoking

      08:20 - 08:40  |  Author(s): V. Beral

      • Abstract

      Loading...

    • +

      PL04.2 - Risk Factors for Lung Cancer in Never-Smokers

      08:40 - 09:00  |  Author(s): C. Chen

      • Abstract

      No abstract available for this presentation

    • +

      PL04.3 - A Critical Review of CT Lung Cancer Screening

      09:00 - 09:20  |  Author(s): E. Quoix

      • Abstract

      No abstract available for this presentation

    • +

      PL04.4 - Biomarker-Driven Programs for Lung Cancer Screening

      09:20 - 09:40  |  Author(s): P.P. Massion

      • Abstract

      Loading...

  • +

    P3.01 - Poster Session 3 - Cancer Biology

    • Type: Poster Session
    • Track: Biology
    • Presentations: 21
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.01-001 - Downregulation of Thymidylate Synthase with Arsenic Trioxide in Non-Small Cell Lung Cancer: in vitro and in vivo

      09:30 - 09:30  |  Author(s): Y.Y. Li

      • Abstract

      Loading...

    • +

      P3.01-002 - Dendritic Cells Promoted the SDF-1-expressing Premetastatic Niche Formation in Mediastinal Lymph Node Metastasis for Lung Cancer via COX-2-derived PGE2-EP3 Signaling.

      09:30 - 09:30  |  Author(s): F. Ogawa

      • Abstract

      Loading...

    • +

      P3.01-003 - Identification and Tumorigenic Role of Mesenchymal Stem Cells from Human Lung Cancer

      09:30 - 09:30  |  Author(s): L. Ampollini

      • Abstract

      Loading...

    • +

      P3.01-004 - Pre-clinical evaluation of Death Receptor-5 activation as a feasible option for K-ras mutant NSCLC therapy

      09:30 - 09:30  |  Author(s): C. Sternberg

      • Abstract

      Loading...

    • +

      P3.01-005 - Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion caused by Pleural Metastasis of Lung Cancer

      09:30 - 09:30  |  Author(s): Y. Zang

      • Abstract

      Loading...

    • +

      P3.01-006 - Discovery of new membrane-associated proteins preferentially expressed in small-cell lung cancer

      09:30 - 09:30  |  Author(s): S. Ocak

      • Abstract

      Loading...

    • +

      P3.01-007 - Energy metabolism in lung adenocarcinoma

      09:30 - 09:30  |  Author(s): C. Hoang

      • Abstract

      Loading...

    • +

      P3.01-008 - The importance of the Secreted Frizzled-Related Protein (SFRP) tumour suppressor gene family and the effect of long-term asbestos exposure on SFRP expression in malignant pleural mesothelioma (MPM)

      09:30 - 09:30  |  Author(s): Y.Y. Cheng

      • Abstract

      Loading...

    • +

      P3.01-009 - FGF-2 induces chemoresistance in model and lung cancer cells through S6K2/hnRNPA1-mediated enhanced translation of anti-apoptotic proteins

      09:30 - 09:30  |  Author(s): M.J. Seckl

      • Abstract

      Loading...

    • +

      P3.01-010 - Tumor-derived microvesicles mediate the transfer of gefitinib resistance in lung cancer cells harboring T790M EGFR mutation

      09:30 - 09:30  |  Author(s): J.Y. Heo

      • Abstract

      Loading...

    • +

      P3.01-011 - Heterogeneity in tumour content and necrosis in primary lung cancers: Implications for molecular analysis

      09:30 - 09:30  |  Author(s): F. Goh

      • Abstract

      Loading...

    • +

      P3.01-012 - Co-targeting the PI3K and MEK pathways in NSCLC: an in vitro evaluation and mutation prevalence in an Irish patient cohort.

      09:30 - 09:30  |  Author(s): S. Heavey

      • Abstract

      Loading...

    • +

      P3.01-013 - KAT5 may be a candidate therapeutic target in Malignant Pleural Mesothelioma

      09:30 - 09:30  |  Author(s): S. Cregan

      • Abstract

      Loading...

    • +

      P3.01-014 - Expression and post-translational modifications of AKT isoforms in Malignant pleural Mesothelioma cells

      09:30 - 09:30  |  Author(s): G. Pinton

      • Abstract

      Loading...

    • +

      P3.01-015 - Outcome in pemetrexed/cisplatin-treated non-small-cell lung cancer (NSCLC) patients according to mRNA expression levels of BRCA1, TS, AEG1 and REV3

      09:30 - 09:30  |  Author(s): B. Massuti

      • Abstract

      Loading...

    • +

      P3.01-016 - Genetic Alterations and Cellular Properties of Acquired Arsenic Resistance in Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): C.Y. Zheng

      • Abstract

      Loading...

    • +

      P3.01-017 - Nitric Oxide Adapted Lung Tumor Cells Express Tumor Stem Cell-Like Markers

      09:30 - 09:30  |  Author(s): A. Dudek

      • Abstract

      Loading...

    • +

      P3.01-018 - Supporting Evidence For A New Tumor Stem Cell Plasticity Model Based On Adaption To Nirtic Oxide

      09:30 - 09:30  |  Author(s): K. Elseth

      • Abstract

      Loading...

    • +

      P3.01-019 - Analysis of Integrins in Malignant Mesothelioma (MM).

      09:30 - 09:30  |  Author(s): N.C. Cheng

      • Abstract

      Loading...

    • +

      P3.01-020 - Bone marrow mesenchymal stem cells deleteriously affect lung cancer cell lines.

      09:30 - 09:30  |  Author(s): V. Zismanov

      • Abstract

      Loading...

    • +

      P3.01-021 - A3 Adenosine Receptor-Mediated p53- Dependent Apoptosis in Lu-65 Human Lung Cancer Cells

      09:30 - 09:30  |  Author(s): T. Otsuki

      • Abstract

      Loading...

  • +

    P3.02 - Poster Session 3 - Novel Cancer Genes and Pathways

    • Type: Poster Session
    • Track: Biology
    • Presentations: 22
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.02-001 - KIF5B/RET fusion gene in surgically-treated Japanese adenocarcinoma of the lung

      09:30 - 09:30  |  Author(s): H. Sasaki

      • Abstract

      Loading...

    • +

      P3.02-002 - Identification of CpG island methylator phenotype predicts the prognosis of small cell lung cancer

      09:30 - 09:30  |  Author(s): Y. Saito

      • Abstract

      Loading...

    • +

      P3.02-003 - ATP7A is a novel determinant of toxicity and response in advanced non-small cell lung cancer patients receiving paclitaxel and carboplatin

      09:30 - 09:30  |  Author(s): B.D. Harris

      • Abstract

      Loading...

    • +

      P3.02-004 - Dysregulation of Hippo tumor-suppressive pathway in malignant mesothelioma

      09:30 - 09:30  |  Author(s): Y. Sekido

      • Abstract

      Loading...

    • +

      P3.02-005 - Genome-wide Identification of Genes with Amplification and/or Fusion in Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): J. Yokota

      • Abstract

      Loading...

    • +

      P3.02-006 - Downregulation of the candidate tumor suppressor gene SIRPA induces senescence mediated by Rb and p27 and is associated with mutation of EGFR

      09:30 - 09:30  |  Author(s): L. Pikor

      • Abstract

      Loading...

    • +

      P3.02-007 - Preferential Expression of MET in Lung Adenocarcinoma vs Lung Squamous-Cell Carcinoma

      09:30 - 09:30  |  Author(s): S. Rost

      • Abstract

      Loading...

    • +

      P3.02-008 - TRIM14 is a Novel Tumor Suppressor Gene in Non-Small-Cell Lung Cancer

      09:30 - 09:30  |  Author(s): J. Hai

      • Abstract

      Loading...

    • +

      P3.02-009 - ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer (NSCLC) patients with the EGFR T790M mutation

      09:30 - 09:30  |  Author(s): N. Karachaliou

      • Abstract

      Loading...

    • +

      P3.02-010 - A PCR-based test detecting ectopic expressions of placenta/germline genes can predict aggressive lung tumours

      09:30 - 09:30  |  Author(s): C.G. Brambilla

      • Abstract

      Loading...

    • +

      P3.02-011 - Quantitative determination of methylation patterns in FHIT and APC genes in non small cell lung cancer (NSCLC): a comparative analysis in tumor tissue, normal lung tissue, peripheral blood, sputum and bronchial aspirate. Correlation with clinical variables.

      09:30 - 09:30  |  Author(s): M.A. Cobo Dols

      • Abstract

      Loading...

    • +

      P3.02-012 - Cysteine dioxygenase 1 (CDO1) : A novel tumor suppressor gene regulated by hypermethylation.

      09:30 - 09:30  |  Author(s): H. Lee

      • Abstract

      Loading...

    • +

      P3.02-013 - ATF2 contributes to Platinum resistance in Non Small Cell Lung Cancer and cJUN/ATF2 Celastrol mediated modulation restores Platinum sensitization.

      09:30 - 09:30  |  Author(s): M. Lo Iacono

      • Abstract

      Loading...

    • +

      P3.02-014 - Interaction between environmental exposure and HPV infection on developing lung cancer among Taiwanese nonsmokers

      09:30 - 09:30  |  Author(s): Y. Cheng

      • Abstract

      Loading...

    • +

      P3.02-015 - Genomic Alteration in sputum samples and DNAfc of Lung Cancer high risk Chilean Population.

      09:30 - 09:30  |  Author(s): M. Adonis

      • Abstract

      Loading...

    • +

      P3.02-016 - Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cells

      09:30 - 09:30  |  Author(s): J. Chorostowska-Wynimko

      • Abstract

      Loading...

    • +

      P3.02-017 - Alpha-catulin/ILK signaling axis could a potential therapeutic target for treating NSCLC metastasis

      09:30 - 09:30  |  Author(s): T. Hong

      • Abstract

      Loading...

    • +

      P3.02-018 - EGFR mutation and its subtypes in Indian population: a study from single academic centre- Tata Memorial Centre

      09:30 - 09:30  |  Author(s): A. Choughule

      • Abstract

      Loading...

    • +

      P3.02-019 - FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)

      09:30 - 09:30  |  Author(s): M.D. Hellmann

      • Abstract

      Loading...

    • +

      P3.02-020 - NSCLC Molecular portrait of the sample of Czech population and indications of targeted therapy

      09:30 - 09:30  |  Author(s): M. Pesek

      • Abstract

      Loading...

    • +

      P3.02-021 - Interdependent role of MUC16/TSPYL5 in lung cancer cell proliferation

      09:30 - 09:30  |  Author(s): A.K. Ganti

      • Abstract

      Loading...

    • +

      P3.02-022 - Deep-Sequencing Mutational Analysis of ATM in NSCLC Cell Lines

      09:30 - 09:30  |  Author(s): L.F. Petersen

      • Abstract

      Loading...